Madrigal Pharmaceuticals, Inc.

NASDAQ (USD): Madrigal Pharmaceuticals, Inc. (MDGL)

Last Price

318.55

Today's Change

-9.64 (2.93%)

Day's Change

317.64 - 329.17

Trading Volume

291,605

Overview

Market Cap

6 Billion

Shares Outstanding

21 Million

Avg Volume

400,471

Avg Price (50 Days)

260.38

Avg Price (200 Days)

251.83

PE Ratio

-12.72

EPS

-25.04

Earnings Announcement

26-Feb-2025

Previous Close

328.19

Open

325.36

Day's Range

317.64 - 329.175

Year Range

168.25 - 368.29

Trading Volume

295,624

Price Change Highlight

1 Day Change

-2.94%

5 Day Change

-3.77%

1 Month Change

-0.32%

3 Month Change

34.75%

6 Month Change

29.76%

Ytd Change

40.42%

1 Year Change

43.50%

3 Year Change

308.24%

5 Year Change

179.99%

10 Year Change

209.57%

Max Change

0.13%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment